| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0314049.8AGB0314049D0 (en) | 2003-06-18 | 2003-06-18 | Therapeutic agents |
| PCT/SE2004/000967WO2004111038A1 (en) | 2003-06-18 | 2004-06-16 | 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0314049.8AGB0314049D0 (en) | 2003-06-18 | 2003-06-18 | Therapeutic agents |
| Publication Number | Publication Date |
|---|---|
| GB0314049D0true GB0314049D0 (en) | 2003-07-23 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0314049.8ACeasedGB0314049D0 (en) | 2003-06-18 | 2003-06-18 | Therapeutic agents |
| Country | Link |
|---|---|
| GB (1) | GB0314049D0 (en) |
| WO (1) | WO2004111038A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006510597A (en) | 2002-09-27 | 2006-03-30 | メルク エンド カムパニー インコーポレーテッド | Substituted pyrimidines |
| CN101132780A (en)* | 2005-02-15 | 2008-02-27 | 爵士制药公司 | Dosage form and method for sustained release of substituted pyrazine compound |
| MX2007012213A (en) | 2005-04-06 | 2007-12-10 | Hoffmann La Roche | Pyridine-3-carboxamide derivatives as cb1 inverse agonists. |
| US7629346B2 (en) | 2006-06-19 | 2009-12-08 | Hoffmann-La Roche Inc. | Pyrazinecarboxamide derivatives as CB1 antagonists |
| US7781593B2 (en) | 2006-09-14 | 2010-08-24 | Hoffmann-La Roche Inc. | 5-phenyl-nicotinamide derivatives |
| EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
| MX2011004258A (en) | 2008-10-22 | 2011-06-01 | Merck Sharp & Dohme | Novel cyclic benzimidazole derivatives useful anti-diabetic agents. |
| CA2741672A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| JP2013520502A (en) | 2010-02-25 | 2013-06-06 | メルク・シャープ・エンド・ドーム・コーポレイション | Novel cyclic benzimidazole derivatives that are useful anti-diabetic drugs |
| US8410107B2 (en) | 2010-10-15 | 2013-04-02 | Hoffmann-La Roche Inc. | N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| US8669254B2 (en) | 2010-12-15 | 2014-03-11 | Hoffman-La Roche Inc. | Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents |
| ES2652662T3 (en) | 2011-02-25 | 2018-02-05 | Merck Sharp & Dohme Corp. | Novel cyclic azabenzimidazole derivatives useful as antidiabetic agents |
| AU2013296470B2 (en) | 2012-08-02 | 2016-03-17 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| CA2898482A1 (en) | 2013-02-22 | 2014-08-28 | Linda L. Brockunier | Antidiabetic bicyclic compounds |
| US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992002513A1 (en)* | 1990-08-06 | 1992-02-20 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic compounds |
| FR2713225B1 (en)* | 1993-12-02 | 1996-03-01 | Sanofi Sa | Substituted N-piperidino-3-pyrazolecarboxamide. |
| MXPA02009258A (en)* | 2000-03-23 | 2005-04-19 | Solvay Pharm Bv | 4,5 dihydro 1h pyrazole derivatives having cb1. |
| SE0104330D0 (en)* | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| SE0104332D0 (en)* | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| Publication number | Publication date |
|---|---|
| WO2004111038A1 (en) | 2004-12-23 |
| Publication | Publication Date | Title |
|---|---|---|
| GB0303910D0 (en) | Therapeutic agents | |
| GB0308318D0 (en) | Therapeutic agents | |
| GB0314079D0 (en) | Therapeutic agents | |
| GB0314057D0 (en) | Therapeutic agents | |
| GB0313250D0 (en) | Therapeutic agents | |
| GB0314261D0 (en) | Therapeutic agents | |
| GB0316237D0 (en) | Therapeutic agents | |
| GB0314049D0 (en) | Therapeutic agents | |
| GB0316232D0 (en) | Therapeutic agents | |
| GB0314129D0 (en) | Therapeutic agents | |
| GB0311859D0 (en) | Therapeutic agents | |
| GB0311201D0 (en) | Therapeutic agents | |
| GB0301350D0 (en) | Therapeutic agents | |
| GB0314136D0 (en) | Therapeutic agents | |
| GB0314130D0 (en) | Therapeutic agents | |
| GB0314260D0 (en) | Therapeutic agents | |
| GB0314134D0 (en) | Therapeutic agents | |
| GB0314075D0 (en) | Therapeutic agents | |
| GB0304524D0 (en) | Therapeutic agents | |
| GB0314131D0 (en) | Therapeutic agents | |
| GB0314078D0 (en) | Therapeutic agents | |
| GB0314051D0 (en) | Therapeutic agents | |
| GB0305823D0 (en) | Therapeutic agents | |
| GB0314053D0 (en) | Therapeutic agents | |
| GB0314042D0 (en) | Therapeutic agents |
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |